| scholarly article | Q13442814 |
| P2093 | author name string | Mark A Turner | |
| P2860 | cites work | Randomized, controlled trial evaluating a baby wash product on skin barrier function in healthy, term neonates | Q24619472 |
| Determining population and developmental pharmacokinetics of metronidazole using plasma and dried blood spot samples from premature infants | Q24626231 | ||
| Innovative clinical trial design for pediatric therapeutics | Q24635308 | ||
| Fluconazole pharmacokinetics and safety in premature infants | Q27014816 | ||
| Randomized trial of drainage, irrigation and fibrinolytic therapy for premature infants with posthemorrhagic ventricular dilatation: developmental outcome at 2 years | Q28275307 | ||
| Effect of fluconazole prophylaxis on candidiasis and mortality in premature infants: a randomized clinical trial | Q30405312 | ||
| Azithromycin to prevent bronchopulmonary dysplasia in ureaplasma-infected preterm infants: pharmacokinetics, safety, microbial response, and clinical outcomes with a 20-milligram-per-kilogram single intravenous dose. | Q30416493 | ||
| Accounting for multiple births in neonatal and perinatal trials: systematic review and case study | Q33748656 | ||
| NeOProM: Neonatal Oxygenation Prospective Meta-analysis Collaboration study protocol | Q33793656 | ||
| Infant skin-cleansing product versus water: a pilot randomized, assessor-blinded controlled trial | Q33899049 | ||
| SCAMP: standardised, concentrated, additional macronutrients, parenteral nutrition in very preterm infants: a phase IV randomised, controlled exploratory study of macronutrient intake, growth and other aspects of neonatal care | Q33929561 | ||
| Managing clinical trials | Q34049734 | ||
| Extrapolation of adult data and other data in pediatric drug-development programs | Q34057100 | ||
| Neurodevelopmental outcomes in the early CPAP and pulse oximetry trial | Q34075235 | ||
| Developmental pharmacology--drug disposition, action, and therapy in infants and children | Q34247047 | ||
| Neuraxial analgesia in neonates and infants: a review of clinical and preclinical strategies for the development of safety and efficacy data. | Q34338289 | ||
| Childhood outcomes after prescription of antibiotics to pregnant women with preterm rupture of the membranes: 7-year follow-up of the ORACLE I trial | Q34597346 | ||
| Randomized controlled trials of antibiotics for neonatal infections: a systematic review | Q34619963 | ||
| The impact of neonatal intensive care practices on the developing brain | Q34694273 | ||
| Population pharmacokinetics of metronidazole evaluated using scavenged samples from preterm infants | Q35867330 | ||
| Risk assessment of neonatal excipient exposure: lessons from food safety and other areas. | Q54589926 | ||
| Parental perception of time and decision-making in neonatal research | Q56781870 | ||
| Top 15 UK research priorities for preterm birth | Q57281265 | ||
| Newborns and drug studies: The NICHD/FDA newborn drug development initiative | Q58392330 | ||
| Plasma aminotransferase concentrations in preterm infants | Q61698277 | ||
| Should newborn infants be excluded from multiple research studies? | Q81765186 | ||
| NO for preterm infants at risk of bronchopulmonary dysplasia | Q84590190 | ||
| Informed consent in the NICU setting: an ethically optimal model for research solicitation | Q35889572 | ||
| Age terminology during the perinatal period | Q35936113 | ||
| Population pharmacokinetics of piperacillin using scavenged samples from preterm infants | Q35965812 | ||
| Neurological and developmental outcome in extremely preterm children born in England in 1995 and 2006: the EPICure studies | Q36445514 | ||
| TIPIT: A randomised controlled trial of thyroxine in preterm infants under 28 weeks' gestation | Q36585122 | ||
| Clinical trials in neonates and children: Report of the pulmonary hypertension academic research consortium pediatric advisory committee. | Q36810827 | ||
| Improving the quality of consent to randomised controlled trials by using continuous consent and clinician training in the consent process | Q36927488 | ||
| Recruitment to randomised trials: strategies for trial enrollment and participation study. The STEPS study | Q37000038 | ||
| An explanatory randomised placebo controlled trial of levothyroxine supplementation for babies born <28 weeks' gestation: results of the TIPIT trial | Q37014390 | ||
| Prioritising neonatal medicines research: UK Medicines for Children Research Network scoping survey | Q37324844 | ||
| Pharmacokinetics of melatonin in preterm infants. | Q37369312 | ||
| Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis? | Q37698200 | ||
| Developmental pharmacokinetics of piperacillin and tazobactam using plasma and dried blood spots from infants | Q37713019 | ||
| A composite outcome for neonatal cardiac surgery research. | Q37731220 | ||
| A structured review of the recent literature on the economic consequences of preterm birth | Q37757783 | ||
| Long-term effects of neonatal drugs on the kidney. | Q37775006 | ||
| Azithromycin, Ureaplasma and chronic lung disease of prematurity: a case study for neonatal drug development | Q37893338 | ||
| Drug studies in newborns: a therapeutic imperative | Q37985058 | ||
| The long-term renal and cardiovascular consequences of prematurity | Q37988805 | ||
| Measuring neurodevelopmental outcome in neonatal trials: a continuing and increasing challenge | Q38120505 | ||
| Clinical trials in neonatal sepsis | Q38125671 | ||
| Intravenous drug delivery in neonates: lessons learnt | Q38183808 | ||
| Paediatric drug development: the impact of evolving regulations | Q38189937 | ||
| Death, bereavement and randomised controlled trials (BRACELET): a methodological study of policy and practice in neonatal and paediatric intensive care trials | Q39166089 | ||
| Adverse drug reactions in neonates | Q40743354 | ||
| Ceftazidime pharmacokinetics in preterm infants: effect of postnatal age and postnatal exposure to indomethacin | Q41763473 | ||
| Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants | Q41923576 | ||
| Glomerular filtration rate reference values in very preterm infants | Q43109210 | ||
| Postnatal head growth in preterm infants: a randomized controlled parenteral nutrition study | Q43471063 | ||
| Long-term follow-up of extremely low birth weight infants with neonatal renal failure | Q44498147 | ||
| Modelling the hierarchical structure in datasets with very small clusters: a simulation study to explore the effect of the proportion of clusters when the outcome is continuous | Q44563796 | ||
| Human renal function maturation: a quantitative description using weight and postmenstrual age. | Q45281878 | ||
| Does neonatal morphine use affect neuropsychological outcomes at 8 to 9 years of age? | Q45821670 | ||
| Childhood outcomes after prescription of antibiotics to pregnant women with spontaneous preterm labour: 7-year follow-up of the ORACLE II trial | Q46356973 | ||
| Dose-finding study of ibuprofen in patent ductus arteriosus using the continual reassessment method | Q46422692 | ||
| Processes in recruitment to randomised controlled trials of medicines for children (RECRUIT): a qualitative study | Q46498288 | ||
| A gestation- and postnatal age-based reference chart for assessing renal function in extremely premature infants | Q46743368 | ||
| Blood loss related to participation in pharmacokinetic study in preterm neonates. | Q50543758 | ||
| Management of hypotension in preterm infants (The HIP Trial): a randomised controlled trial of hypotension management in extremely low gestational age newborns. | Q50684310 | ||
| An algorithm to detect adverse drug reactions in the neonatal intensive care unit. | Q51260077 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | research ethics | Q1132684 |
| medical ethics | Q237151 | ||
| P304 | page(s) | 370-378 | |
| P577 | publication date | 2015-03-01 | |
| P1433 | published in | British Journal of Clinical Pharmacology | Q176044 |
| P1476 | title | Clinical trials of medicines in neonates: the influence of ethical and practical issues on design and conduct | |
| P478 | volume | 79 |
| Q90225732 | A universal right to pain relief: balancing the risks in a vulnerable patient population |
| Q89598857 | Barriers and Challenges in Performing Pharmacokinetic Studies to Inform Dosing in the Neonatal Population |
| Q93107049 | Issues, challenges, and the way forward in conducting clinical trials among neonates: investigators' perspective |
| Q38469763 | Neonatal medicines research: challenges and opportunities |
| Q42586100 | Paediatric prescribing: why children are not small adults |
| Q52575612 | Pharmacokinetic-Pharmacodynamic Modeling in Pediatric Drug Development, and the Importance of Standardized Scaling of Clearance. |
| Q90745655 | Recommendations for the design of therapeutic trials for neonatal seizures |
| Q47428031 | Safety, dosing, and pharmaceutical quality for studies that evaluate medicinal products (including biological products) in neonates |
| Q38809090 | The prevalence of child-specific utilities in NICE appraisals for paediatric indications: rise of the economic orphans? |
Search more.